Mutations in the binding site of TNFR1 PLAD reduce homologous interactions but can enhance antagonism of wild‐type TNFR1 activity
Sarah Albogami(Taif University), Patrick J. Tighe(University of Florida)
Cited by 6
Related Papers
Chimeric Antigen Receptor T-Cells: An Overview of Concepts, Applications, Limitations, and Proposed Solutions
|Frontiers in Bioengineering and Biotechnology|2022|136
Designing of a Multi-epitope Vaccine against the Structural Proteins of Marburg Virus Exploiting the Immunoinformatics Approach
|ACS Omega|2021|105
KPNA2 is a nuclear export protein that contributes to aberrant localisation of key proteins and poor prognosis of breast cancer
|British Journal of Cancer|2015|76
A Computational Approach to Elucidate the Interactions of Chemicals From Artemisia annua Targeted Toward SARS-CoV-2 Main Protease Inhibition for COVID-19 Treatment
|Frontiers in Medicine|2022|61
Metformin and growth differentiation factor 15 (<scp>GDF15</scp>) in type 2 diabetes mellitus: A hidden treasure
|Journal of Diabetes|2022|60